7 December 2017Big Pharma
CJEU rules on marketing authorisations and SPCs
An end of procedure notice issued by a reference EU member state before the expiry of a basic patent may not be treated as equivalent to a marketing authorisation (MA).
An end of procedure notice issued by a reference EU member state before the expiry of a basic patent may not be treated as equivalent to a marketing authorisation (MA).
